$ACHV
ACHIEVE LIFE SCIENCES, INC.

2017 Q1 Form 10-Q Financial Statement

#000156459017010905 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016 Q1
Revenue $0.00 $0.00 $2.940M
YoY Change -100.0% -100.0% 113.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.530M $2.300M $2.300M
YoY Change 10.0% -21.23% -14.81%
% of Gross Profit
Research & Development $61.00K $80.00K $65.00K
YoY Change -6.15% -98.79% -98.23%
% of Gross Profit
Depreciation & Amortization $93.00K $40.00K $56.00K
YoY Change 66.07% -33.33% 21.74%
% of Gross Profit
Operating Expenses $61.00K $80.00K $7.372M
YoY Change -99.17% -98.79% 15.71%
Operating Profit
YoY Change
Interest Expense $30.00K $40.00K $50.00K
YoY Change -40.0% 33.33% 0.0%
% of Operating Profit
Other Income/Expense, Net -$8.000K -$4.000K -$6.000K
YoY Change 33.33% -100.23% -101.25%
Pretax Income -$329.0K -$5.840M -$3.710M
YoY Change -91.13% 239.53% -17.92%
Income Tax
% Of Pretax Income
Net Earnings -$205.0K -$486.0K -$242.0K
YoY Change -15.29% -71.78% -94.64%
Net Earnings / Revenue -8.23%
Basic Earnings Per Share
Diluted Earnings Per Share -$327.0M -$584.0M -$371.0M
COMMON SHARES
Basic Shares Outstanding 30.09M 30.02M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $784.0K $10.25M $46.11M
YoY Change -98.3% -51.08% 14.14%
Cash & Equivalents $24.00K $15.00K $18.91M
Short-Term Investments $760.0K $10.23M $27.20M
Other Short-Term Assets $800.0K $1.000M $233.0K
YoY Change 243.35% 7042.86% -53.31%
Inventory
Prepaid Expenses $765.0K $3.000K
Receivables $237.0K $478.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.45M $18.00K $47.99M
YoY Change -63.63% -99.97% 5.45%
LONG-TERM ASSETS
Property, Plant & Equipment $166.0K $300.0K $546.0K
YoY Change -69.6% -50.0% 31.25%
Goodwill $1.034M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.00K $300.0K $38.00K
YoY Change -65.79% 0.0% -86.03%
Total Long-Term Assets $451.0K $3.789M $856.0K
YoY Change -47.31% 320.07% -2.51%
TOTAL ASSETS
Total Short-Term Assets $17.45M $18.00K $47.99M
Total Long-Term Assets $451.0K $3.789M $856.0K
Total Assets $17.90M $3.807M $48.84M
YoY Change -63.34% -93.46% 5.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $359.0K $95.00K $592.0K
YoY Change -39.36% -92.69% -40.08%
Accrued Expenses $1.400M $6.000M $10.10M
YoY Change -86.14% -49.58% -11.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $1.980M $3.073M $14.50M
YoY Change -86.34% -85.13% -10.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% 0.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.980M $3.073M $14.50M
Total Long-Term Liabilities $0.00 $0.00 $100.0K
Total Liabilities $2.012M $3.197M $14.60M
YoY Change -86.22% -84.61% -10.79%
SHAREHOLDERS EQUITY
Retained Earnings -$200.2M -$2.062M
YoY Change -98.83%
Common Stock $213.5M $2.696M
YoY Change -98.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.89M $610.0K $34.20M
YoY Change
Total Liabilities & Shareholders Equity $17.90M $3.807M $48.80M
YoY Change -63.31% -93.46% 5.21%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016 Q1
OPERATING ACTIVITIES
Net Income -$205.0K -$486.0K -$242.0K
YoY Change -15.29% -71.78% -94.64%
Depreciation, Depletion And Amortization $93.00K $40.00K $56.00K
YoY Change 66.07% -33.33% 21.74%
Cash From Operating Activities -$9.000M -$6.980M -$9.090M
YoY Change -0.99% -34.64% 41.15%
INVESTING ACTIVITIES
Capital Expenditures $1.000K -$10.00K
YoY Change -85.71%
Acquisitions
YoY Change
Other Investing Activities $9.470M $10.42M -$6.310M
YoY Change -250.08% 305.45% -254.66%
Cash From Investing Activities $9.470M $10.42M -$6.310M
YoY Change -250.08% 316.8% -262.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -9.000M -6.980M -9.090M
Cash From Investing Activities 9.470M 10.42M -6.310M
Cash From Financing Activities -20.00K 0.000 0.000
Net Change In Cash 9.000K 3.440M -15.40M
YoY Change -100.06% -142.11% 490.04%
FREE CASH FLOW
Cash From Operating Activities -$9.000M -$6.980M -$9.090M
Capital Expenditures $1.000K -$10.00K
Free Cash Flow -$9.001M -$6.970M
YoY Change -34.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
478000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
954000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
272000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
17452000
CY2017Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
765000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
30000
CY2017Q1 us-gaap Short Term Investments
ShortTermInvestments
760000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
237000
CY2017Q1 us-gaap Assets
Assets
17903000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
359000
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
834000
CY2017Q1 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
342000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
210000
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
55000
CY2017Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
180000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1980000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
213450000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-200230000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2641000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
15891000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17903000
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
232000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
49000
CY2016Q4 us-gaap Liabilities
Liabilities
8504000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27470000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30059514
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30025521
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2532000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2299000
CY2017Q1 ogxi Restructuring Costs Recovery
RestructuringCostsRecovery
-98000
CY2016Q1 ogxi Restructuring Costs Recovery
RestructuringCostsRecovery
431000
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
3346000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
213239000
CY2017Q1 us-gaap Liabilities
Liabilities
2012000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
18966000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
29000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196942000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2640000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8455000
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
32000
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30121478
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30087485
CY2016Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
2940000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
912000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4642000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
77000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
725000
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
7372000
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
27000
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
48000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-241000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
219000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-189000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-401000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1762000
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-667000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3269000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-3707000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3268000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3693000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30076160
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29827824
CY2017Q1 us-gaap Depreciation
Depreciation
93000
CY2016Q1 us-gaap Depreciation
Depreciation
56000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
211000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
468000
CY2017Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
98000
CY2017Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-32000
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-58000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-751000
CY2017Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1510000
CY2016Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
268000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3073000
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1516000
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
22000
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-523000
CY2017Q1 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
19000
CY2016Q1 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
14000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2941000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8995000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9087000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
19000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-19000
CY2017Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
5000
CY2016Q1 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
24169000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
9475000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
17859000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
9469000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6310000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
457000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15397000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34310000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18913000
CY2017Q1 ogxi Reversion Rights Period
ReversionRightsPeriod
P90D
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
180000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
232000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
52000
CY2017Q1 us-gaap Cash
Cash
2728000
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
760000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
760000
CY2017Q1 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
93175
CY2016Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
101228
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9446
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30173
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1339186
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.62
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
21.05
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.75
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.59
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0152
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7180
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
400000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
600000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5200000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000
CY2017Q1 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2016Q1 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2017Q1 us-gaap Contractual Obligation
ContractualObligation
400000
CY2017Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
353000
CY2017Q1 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
33000
CY2017Q1 us-gaap Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
9000
CY2017Q1 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
5000
CY2017Q1 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2016-09
CY2015Q3 ogxi Expansion Of Rental Space Notice Provided
ExpansionOfRentalSpaceNoticeProvided
2245
CY2017Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
CY2015Q1 ogxi Additional Contingent Liability Early Termination Of Lease Agreement
AdditionalContingentLiabilityEarlyTerminationOfLeaseAgreement
1300000
CY2017Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2017Q1 ogxi Indemnification Expense
IndemnificationExpense
0
CY2016Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
11
CY2016Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.27
CY2016Q1 us-gaap Severance Costs1
SeveranceCosts1
400000
CY2016Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
14
CY2016Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.48
CY2016Q4 us-gaap Severance Costs1
SeveranceCosts1
1000000
CY2016Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
5
CY2016Q4 us-gaap Severance Costs1
SeveranceCosts1
700000
CY2017Q1 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
2206000
CY2017Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-98000
CY2017Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
2052000
CY2017Q1 us-gaap Restructuring Reserve
RestructuringReserve
56000

Files In Submission

Name View Source Status
0001564590-17-010905-index-headers.html Edgar Link pending
0001564590-17-010905-index.html Edgar Link pending
0001564590-17-010905.txt Edgar Link pending
0001564590-17-010905-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ogxi-10q_20170331.htm Edgar Link pending
ogxi-20170331.xml Edgar Link completed
ogxi-20170331.xsd Edgar Link pending
ogxi-20170331_cal.xml Edgar Link unprocessable
ogxi-20170331_def.xml Edgar Link unprocessable
ogxi-20170331_lab.xml Edgar Link unprocessable
ogxi-20170331_pre.xml Edgar Link unprocessable
ogxi-ex21_418.htm Edgar Link pending
ogxi-ex311_7.htm Edgar Link pending
ogxi-ex312_8.htm Edgar Link pending
ogxi-ex321_10.htm Edgar Link pending
ogxi-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending